ArticleAnnals of surgical oncology2025

Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer.

Won-Gun Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.